Active Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
IBP2; IGF-BP53
- UOM
- FOB US$ 280.00 US$ 700.00 US$ 1,400.00 US$ 4,200.00 US$ 10,500.00
- Quantity
Overview
Properties
- Product No.APA053Hu61
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- ApplicationsCell culture; Activity Assays.
Research use only - Downloadn/a
- CategoryTumor immunityEndocrinology
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
- Traits Freeze-dried powder, Purity > 90%
- Isoelectric Point7.9
Share your citation
Upload your experimental result
Review
Leave a message
Loading...
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Please attach serial No. on instruction manual

Contact us
Please fill in the blank.
Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code*
Activity test
Usage
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Increment services
-
BCA Protein Quantification Kit
-
Molecular Mass Marker for Protein
-
Monoclonal Antibody Customized Service
-
Polyclonal Antibody Customized Service
-
Protein Activity Test Experiment Service
-
Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
-
Buffer
-
Lentivirus Packaging Experiment Service
-
Adenovirus Packaging Experiment Service
-
Real Time PCR Experimental Service
-
Spike RBD Protein (S-RBD)
-
Protein G
-
Protein A
Citations
- A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.pubmed:28664912
- Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MSDoi: 10.3892/etm.2018.6818
- Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung CancerPubmed: 32286106